4.8 Article

The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery

期刊

NUCLEIC ACIDS RESEARCH
卷 45, 期 W1, 页码 W42-W48

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkx360

关键词

-

资金

  1. German Center for Infectious Biology [DZIF 9.704]
  2. Novo Nordisk Foundation
  3. College of Pharmacy Research Startup Funds
  4. American Society of Pharmacognosy Research Starter Grant
  5. NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish
  6. Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish

向作者/读者索取更多资源

With the rise of multi-drug resistant pathogens and the decline in number of potential new antibiotics in development there is a fervent need to reinvigorate the natural products discovery pipeline. Most antibiotics are derived from secondary metabolites produced by microorganisms and plants. To avoid suicide, an antibiotic producer harbors resistance genes often found within the same biosynthetic gene cluster (BGC) responsible for manufacturing the antibiotic. Existing mining tools are excellent at detecting BGCs or resistant genes in general, but provide little help in prioritizing and identifying gene clusters for compounds active against specific and novel targets. Here we introduce the 'Antibiotic Resistant Target Seeker' (ARTS) available at https://arts.ziemertlab.com. ARTS allows for specific and efficient genomemining for antibiotics with interesting and novel targets. The aim of this web server is to automate the screening of large amounts of sequence data and to focus on the most promising strains that produce antibiotics with new modes of action. ARTS integrates target directed genome mining methods, antibiotic gene cluster predictions and 'essential gene screening' to provide an interactive page for rapid identification of known and putative targets in BGCs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据